"The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses"...
Additional Mylotarg Information
Mylotarg - User Reviews
Report Problems to the Food and Drug Administration
Find out what women really need.